To improve security and privacy, we are moving our web pages and services from HTTP to HTTPS. To give users of web services time to transition to HTTPS, we will support separate HTTP and HTTPS services until the end of 2017. From January 2018 most HTTP traffic will be automatically redirected to HTTPS. [more...] View this page in https
Thyroglobulin (Tg) is a large glycoprotein specific to the thyroid gland and
it is the precursor of the iodinated thyroid hormones thyroxine (T4) and
triiodothyronine (T3). The N-terminal section of Tg contains 11 repeats of a
domain of about 70 amino acids which is known as the Tg type-1 repeat [1,2,3].
Such a domain has also been found (as a single or repeated sequence) in the
proteins listed below:
In the HLA class II associated invariant chain . In that protein the
type-1 repeat is encoded by an exon which is alternatively spliced and is
only present in a longer form of the protein.
In human pancreatic carcinoma marker proteins GA733-1 and GA733-2 (which is
also known as epithelial cell surface antigen (EPG) or adenocarcinoma-
associated antigen (KSA) or antigen KS 1/4). These proteins may function as
growth factor receptors .
In nidogen (entactin), a sulfated glycoprotein which is widely distributed
in basement membranes and that is tightly associated with laminin. Nidogen
probably has a role in cell-extracellular matrix interactions.
In the insulin-like growth factor binding proteins (IGFBP)  (see
In saxiphilin, a transferrin-like protein from frog that binds specifically
to the neurotoxin saxitoxin .
In equistatin, a thiol-protease inhibitor from sea anemone .
The domain contains six cysteines (Tg type-1a) involved in 3 disulfide bonds
(see <PDB:1ZT3>) , but also exists in a variant that lacks the third and
fourth cysteines (Tg type-1b). One Gln residue is strongly conserved.
Schematic representations of the two Tg type-1 domains are shown below:
PROSITE is copyright. It is produced by the SIB Swiss Institute
Bioinformatics. There are no restrictions on its use by non-profit
institutions as long as its content is in no way modified. Usage by and
for commercial entities requires a license agreement. For information
about the licensing scheme send an email to
or see: prosite_license.html.